May and Baker Nigeria Plc (MAYBAKER) sustained a double-digit topline expansion for the third consecutive year in 2022FY. The firm’s topline expansion was anchored mainly by both increased sales volumes and price increments on products in the pharmaceutical segment (including some analgesic, anti-hypertensive, and anti-infective products).
Earnings Update – MAYBAKER 2022FY
